Article
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
Clinical neuropharmacology - 1 Jan 2022
Beanes Graziele, Caliman-Fontes Ana Teresa, Souza-Marques Breno, Silva Hátilla Dos Santos, Leal Gustavo C, Carneiro Beatriz Alves, Guerreiro-Costa Lívia N F, Figueiredo Alexandre V, Figueiredo Camila Alexandrina V, Lacerda Acioly L T, Costa Ryan Dos S, Quarantini Lucas C
Abstract excerpt
OBJECTIVE: This study aimed to evaluate the effect of genetic variants in glutamate ionotropic receptor N-methyl- d -aspartate type subunit 2B ( GRIN2B ), glutamate ionotropic receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid type subunit 1 ( GRIA1 ), and brain-derived neurotrophic factor ( BDNF ) genes on therapeutic response, remission, and total Montgomery-Åsberg Depression Rating Scale scores...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
